http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109718366-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_795cb009fbe52eb9be778ed97897534c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b862ce4493b6cf60050e4bd9b43622da |
| publicationDate | 2019-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109718366-A |
| titleOfInvention | A kind of pharmaceutical composition and its application for treating hepatocellular carcinoma |
| abstract | The invention discloses a kind of pharmaceutical compositions and its application for treating hepatocellular carcinoma, its effective component includes dual tyrosine-(Y)-phosphorylated regulation kinases 3, dual tyrosine-(the Y)-phosphorylated regulation kinases 3 carries out phosphorylation to NCOA3, destroy the combination of NOCA3 and ATF4, cause the inhibition of the transcriptional activity of ATF4, to lower the generation of purine metabolism, the growth and metastasis of tumours in HCC Xenograft Tumor Models is significantly suppressed. |
| priorityDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.